This is what the gateway will look like once the work is complete Work has begun to create a high-quality incubator space in the heart of The London Cancer Hub in Sutton. The space - known as Innovation Gateway - is a significant step in The London Cancer Hub development, which aims to create the world’s leading district for cancer research, treatment and commercial enterprise. The Innovation Gateway will offer companies the chance to work side by side with world-class scientists at The Institute of Cancer Research (ICR) within mixed laboratory, office and collaboration space. It is due to open in late 2021 and will be home to a range of companies related to cancer, with a particular emphasis on accommodating start-ups, spin-outs and small teams from the biotech, medtech, data science and pharmaceutical industries.
(1)
Vancouver, British Columbia (Newsfile Corp. - March 16, 2021) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ( BioMark ) is pleased to announce today that its sponsored research collaboration with The Metabolomics Innovation Centre (TMIC) was successful in receiving funding from the Novel Technology Application in Cancer Prevention and Early Detection Spark Grants competition. This comes after the organizers of the competition, the Canadian Cancer Society/Canadian Institutes of Health Research - Institute of Cancer Research, and Brain Canada Foundation, evaluated the full proposal for its relevance to funding opportunities in the prevention and early detection of cancer. The funding application is entitled A novel rapid, liquid biopsy early-stage lung cancer diagnostic test . The grant was for $150,000.
Six Imperial researchers awarded leading health honours miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
AI Algorithm can Help Predict Bacterial Infections, Develop New Treatments
Written by AZoRoboticsMar 12 2021
A better understanding of how bacterial proteins function together as a network to take control of human cells could help estimate the outcomes of infections and design novel treatments.
Image Credit: Pashkova/shutterstock.com
Salmonella and
E. coli, are similar to how a hacker takes control of an organization’s software to create chaos. These microorganisms use tiny molecular syringes to administer their own chaos-inducing agents (known as effectors) inside the cells that keep the human gut healthy.
Such effectors seize control of the human cells, which overwhelm their defense systems and inhibit the crucial immune responses, thus enabling the infection to take hold.
Three-drug combination moves forward for advanced breast cancer 11
Image: Breast cancer cells. Credit: Ewa Krawczyk
A combination of three drugs is safe and shows signs of effectiveness in treating some patients with previously treated advanced breast cancer, a clinical trial shows.
The ‘triplet therapy’ combines the hormone therapy fulvestrant with two targeted drugs, called palbociclib and taselisib, that block cells from multiplying and dividing.
A total of 78 patients with breast or other cancers were enrolled in the trial, and were given either the triplet therapy or a ‘doublet’ therapy of the targeted drugs without fulvestrant.
The triplet therapy showed particular promise in the 25 patients with advanced and previously treated oestrogen receptor positive, HER-2 negative breast cancer with mutations in the